KYMERA THERAPEUTICS, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 34.5 USD | +3.37% |
|
+0.20% | +35.19% |
Chart calendar Kymera Therapeutics, Inc.
01ca69e5a8bee6c58.UPlsv7zb_7wR3eXRKDqkiMlBYob9JPUcCOoGdZ-v5FA.Zp4P8fGPj49gl5-LYnnj2Lx0F_OwYLZ5fZN-LNfaohIHki2O1b2q7Guajg~350a76095f6358a5424c843306b27dc3
Upcoming events on Kymera Therapeutics, Inc.
Past events on Kymera Therapeutics, Inc.
| 09/04/2024 10:46 pm | American Association for Cancer Research Meeting |
| 08/04/2024 02:00 am | American Association for Cancer Research Meeting - Abstract No: LB037/19 |
| 28/03/2024 08:00 pm | H.C. Wainwright Autoimmune & Inflammatory Disease Virtual Conference |
| 13/03/2024 | Jefferies Biotech on the Bay Summit |
| 13/03/2024 01:10 am | Leerink Partners Global Biopharma Conference |
| 06/03/2024 11:20 pm | TD Cowen Health Care Conference |
| 22/02/2024 07:00 pm | Q4 2023 Earnings Call |
| 22/02/2024 05:30 pm | Q4 2023 Earnings Release |
| 07/02/2024 08:00 pm | Guggenheim Healthcare Talks Biotechnology Conference - Fireside Chat |
| 09/01/2024 10:30 pm | JPMorgan Healthcare Conference |
| 04/01/2024 08:30 pm | R&D Day |
| 11/12/2023 07:30 am | American Society of Hematology Meeting - A STAT3 Degrader Demonstrates |
| 11/12/2023 | Investor Meeting |
| 11/12/2023 07:30 am | American Society of Hematology Meeting - Preliminary Safety, Pharmacokinetics |
| 29/11/2023 11:00 pm | Evercore ISI HealthCONx Conference |
| 28/11/2023 11:00 pm | Piper Sandler Healthcare Conference |
| 16/11/2023 12:55 am | Stifel Healthcare Conference |
| 09/11/2023 | Truist Securities Healthcare Conference |
| 08/11/2023 09:00 pm | UBS BioPharma Conference |
| 07/11/2023 | J.P. Morgan Equity Opportunities Forum |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 2,93 | 34,0 42,0 -19% | 72,8 83,7 -12.99% | 46,8 50,2 -6.73% | 78,6 69,4 13.3% | 52,9 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -44,5 -39,3 -13.3% | -98,1 -72,8 -34.71% | -158 -152 -3.99% | -162 -169 4.06% | -200 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -46,3 -41,8 -10.88% | -101 -95,8 -4.96% | -161 -155 -4.16% | -166 -172 3.5% | -228 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -45,6 -39,5 -15.52% | -100 -96,2 -4.15% | -155 -154 -0.39% | -147 -160 8.22% | -217 |
|
Net income Million USD | Released Forecast Spread | 0,00 | -54,6 -42,7 -27.9% | -100 -95,5 -4.9% | -155 -153 -1.29% | -147 -155 5.14% | -218 |
|
EPS USD | Released Forecast Spread | 0,00 | -3,15 -1,61 -95.96% | -2,09 -2,00 -4.7% | -2,87 -2,92 1.87% | -2,52 -2,65 4.84% | -3,23 |
| Announcement Date | 31/07/20 | 11/03/21 | 24/02/22 | 23/02/23 | 22/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 15,3 21,3 -28.33% | 9,62 18,7 -48.44% | 11,5 15,0 -23.08% | 9,55 15,9 -40.1% | 16,1 20,7 -21.89% | 9,47 14,2 -33.12% | 16,5 13,7 20.17% | 4,73 16,0 -70.4% | 47,9 42,0 14.02% | 13,1 | 11,2 | 9,52 | 13,1 | 22,8 |
|
EBITDA Million USD | Released Forecast Spread | -33,3 -19,2 -73.45% | -18,4 -36,6 49.65% | -50,7 | -49,1 | -64,6 | |||||||||
|
EBIT Million USD | Released Forecast Spread | -34,0 -28,9 -17.6% | -36,9 -33,8 -9.16% | -40,8 -34,6 -17.97% | -44,9 -38,2 -17.53% | -38,6 -34,2 -13.08% | -45,3 -41,0 -10.67% | -43,4 -42,4 -2.4% | -57,5 -43,5 -32.15% | -19,3 -25,0 22.9% | -53,2 | -56,4 | -60,6 | -58,3 | -57,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -33,9 -29,5 -14.91% | -36,7 -37,2 1.39% | -40,3 -37,6 -6.98% | -43,0 -39,6 -8.53% | -34,9 -35,6 1.96% | -40,9 -41,3 0.98% | -38,8 -40,0 3.04% | -52,9 -42,0 -25.84% | -14,4 -19,0 24.42% | -47,2 | -52,1 | -57,4 | -55,1 | -73,5 |
|
Net income Million USD | Released Forecast Spread | -33,9 -28,9 -17.27% | -36,7 -37,4 1.9% | -40,3 -37,0 -8.86% | -43,0 -39,0 -10.26% | -34,9 -33,6 -3.7% | -40,9 -40,9 -0.06% | -38,8 -41,5 6.43% | -52,9 -42,9 -23.14% | -14,4 -17,2 16.39% | -48,5 | -52,6 | -57,1 | -56,6 | -73,5 |
|
EPS USD | Released Forecast Spread | -0,67 -0,57 -17.71% | -0,71 -0,66 -7.25% | -0,78 -0,70 -11.54% | -0,79 -0,74 -6.07% | -0,59 -0,63 6.38% | -0,70 -0,71 1.09% | -0,67 -0,73 7.85% | -0,90 -0,71 -26.63% | -0,25 -0,31 19.29% | -0,73 | -0,77 | -0,82 | -0,80 | -0,81 |
| Announcement Date | 24/02/22 | 03/05/22 | 09/08/22 | 03/11/22 | 23/02/23 | 04/05/23 | 03/08/23 | 02/11/23 | 22/02/24 | - | - | - | - | - |
| Today 01:35 am | QIAGEN N.V.: Q1 2024 Earnings Release |
| 30/04/2024 | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | AZENTA, INC.: Q2 2024 Earnings Release (Projected) |
| 01/05/2024 04:00 pm | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
| 01/05/2024 04:00 pm | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
| 01/05/2024 04:30 pm | ALKERMES PLC: Q1 2024 Earnings Release |
| 02/05/2024 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
Past sector events for Kymera Therapeutics, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- KYMR Stock
- Calendar Kymera Therapeutics, Inc.
